Halma Plc acquires Rovers Medical Devices BV for $73Mln in cash, with additional €6M based on performance, for cervical cancer prevention devices.
Halma Plc, a technology conglomerate, has acquired Rovers Medical Devices BV for an initial $73Mln (€85M) in cash, with an additional €6M payable based on Rovers' performance until 2025. Rovers, based in the Netherlands, designs and manufactures devices for cervical cancer prevention and diagnostics. The acquired company will be a standalone within Halma's Healthcare sector and managed by its current team.
March 04, 2024
3 Articles